Interestingly, 72% and 73% of endometrial tumors with DHODH overexpression co-occurrence with a POLE and POLD1 mutation are significantly associated with high-grade tumor stages, respectively (Figure 5E,F, ** p < 0.01, **** p < 0.0001). Here, POLE is linked to endometrium neoplasm.